Compendia as Authoritative Sources for Use in the Determination of a "Medically Accepted Indication" of Drugs and Biologicals Used Off-Label in an Anti-Cancer Chemotherapeutic Regimen
CMS is recognizing four authoritative compendia and listing them in chapter 15, section 50.4.5 of the Medicare Benefit Policy Manual for use in the determination of a medically accepted indication of drugs and biologicals used off-label in an anti-cancer chemotherapeutic regimen.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: October 24, 2008
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.